Pavicic, P. G., Rayman, P. A., Swaidani, S., Rupani, A., Makarov, V., Tannenbaum, C. S., . . . Mahdi, H. Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression. Taylor & Francis Group.
Chicago Style (17th ed.) CitationPavicic, Paul G., et al. Immunotherapy with IL12 and PD1/CTLA4 Inhibition Is Effective in Advanced Ovarian Cancer and Associates with Reversal of Myeloid Cell-induced Immunosuppression. Taylor & Francis Group.
MLA (9th ed.) CitationPavicic, Paul G., et al. Immunotherapy with IL12 and PD1/CTLA4 Inhibition Is Effective in Advanced Ovarian Cancer and Associates with Reversal of Myeloid Cell-induced Immunosuppression. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.